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Chlamydia psittaci and Chlamydia trachomatis elementary bodies (EB) incubated in the presence of
complement or specific antibody or both caused chemotaxis of human polymorphonuclear leukocytes (PMN) in
vitro. Reticulate bodies and culture supernatants had no effect on these cells. The ability of chlamydiae to enter
and survive in PMN under nonopsonizing conditions was investigated by measuring the association of
3H-labeled EB and of inclusion-forming units with these phagocytes. Both assays indicated that C. psittaci as
well as C. trachomatis EB are efficiently internalized. The mechanism by which this is accomplished is distinct
from classical phagocytosis in that it is not dependent upon the presence of complement or antibody.
Furthermore, uptake of at least C. psittaci appeared to be rapid, with no additional increase occurring after 15
min. The majority of 'cell-associated chlamydiae were rendered acid soluble or noninfectious within 1 h.
Subsequently, there was a small but steady loss of infectivity for up to 10 h, which may have been due to the
conversion of EB to the noninfectious reticulate-body form of the organism. However, even at 10 h after entry
a small percentage of bacteria was still capable of infecting a second target cell. This is noteworthy in that PMN
are relatively short-lived cells, and after lysis, intracellular organisms may be free to infect adjacent tissue.
Electron microscopic observations were consistent with the data on uptake and persistence. The ability of a
small percentage of infecting chlamydiae to maintain infectivity in PMN for at least several hours may enable
these organisms subsequently to establish productive infection in permissive host cells.
A number of chlamydial infections are associated with a
response by polymorphonuclear leukocytes (PMN) in the
affected tissues. The pathology associated with human psit-
tacosis includes inflammatory exudate within the alveoli in
which PMN are prominent (22). Investigators have also
observed a strong correlation between genital infection with
Chlamydia trachomatis and the appearance of large numbers
of PMN in male urethral smears and in endocervical mucus
(1, 4). In addition, individuals afflicted with trachoma display
infiltration of PMN in the conjunctival epithelium and
subepithelium in the first stages of the disease (8). This
observation was expanded upon by Yoneda and co-workers
(29) in a study involving children of southern Tunisia, where
trachoma is hyperendemic. They found that the presence of
numerous PMN in conjunctival smears, in addition to other
cytological features, was a useful indicator for the presence
of chlamydial inclusions.
Although PMN are generally the first inflammatory cells to
infiltrate the site of infection, little information is available
on the role of these professional phagocytes in combating
chlamydial infection. Using a mouse model system, Tuffrey
and colleagues observed that genital C. trachomatis infec-
tion was suppressed by a concurrent infection with
Mycoplasma pulmonis (26). They hypothesized that the
increased intensity and duration of the PMN response in
doubly infected mice may have been responsible for the
elimination of the Chlamydia sp. The question of whether
PMN are capable of killing C. trachomatis was investigated
more directly by Yong et al. (30), who suggested that human
PMN are capable of eradicating C. trachomatis at low
chlamydia/PMN ratios. Some investigators have used
luminol-dependent chemiluminescence to approximate the
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chlamydiacidal activity of PMN. However, conflicting re-
sults have been obtained in different laboratories (12, 23).
The purpose of our study was to examine more completely
the effects that Chlamydia spp. and human PMN have on
one another in vitro. Clearly, the complexity of this interac-
tion in vivo cannot be precisely duplicated in a test tube.
However, we believe that knowledge of the role of this
cellular immune defense mechanism in the control and
elimination of infection will provide additional insight into
the pathogenesis of these organisms.
MATERIALS AND METHODS
Growth and purification of Chlamydia spp. The CAL10
meningopneumonitis strain of Chlamydia psittaci was grown
in L-929 suspension cells by the method of Tamura and
Higashi (24). Elementary bodies (EB) were harvested at 48 h
postinfection. Intracellular organisms were released by
sonication of infected cells and pooled with the cell-free
supernatants. EB were purified as reported previously by
differential centrifugation and centrifugation through 30%
sucrose cushions and discontinuous gradients of 38, 44, and
59% Renografin-76 (28). C. psittaci reticulate bodies (RB)
were purified by using potassium tartrate gradients as
described previously (25). Phagosomes containing C. psittaci
RB were obtained by the method of Matsumoto (15).
C. trachomatis biovar E/UW-5/Cx was grown in McCoy
cell monolayers essentially by the method of Newhall et al.
(19). Before infection, McCoy cells were pretreated with
DEAE-dextran (30 ,ug/ml) at 37°C for 20 min. The organisms,
suspended in a volume of 0.5 ml, were adsorbed to McCoy
cells in 75-cm2 tissue culture flasks for 90 min at 25°C. Fresh
medium containing cycloheximide (0.5 Rg/ml) was added to
the flasks, which were incubated at 35°C in an atmosphere of
5% CO2. Infected McCoy cells were detached from flasks
with a rubber policeman 72 h after inoculation. The contents
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of the flasks were transferred to bottles containing 3-mm
sterile glass beads and sonicated for 5 min in a water bath.
EB were partially purified by differential centrifugation and
density gradient centrifugation in Percoll (19).
Infectivity of C. psittaci and C. trachomatis was deter-
mined by using a modification of the inclusion-forming unit
technique (14). Dilutions of EB were added to L-cell or
McCoy cell monolayers on 12-mm2 cover slips in 1-dram
vials and centrifuged at 282 x g for 30 min. Inclusions
stained with Giemsa (Gurr; BDH Chemicals Ltd., Poole,
England) were counted after a 24-h incubation at 37°C for C.
psittaci, or a 48-h incubation at 35°C for C. trachomatis. The
percent infectivity was calculated as the number of infec-
tious particles per total particles (determined spectrophoto-
metrically) multiplied by 100.
To obtain radioisotopically labeled chlamydiae, the meth-
ods of Eissenberg et al. (10) were employed. The majority of
experiments were performed with EB internally labeled with
[3H]uridine (1 mCi/liter of culture). For comparison some
experiments were done with EB surface labeled with N-
[3H]succinimidyl proprionate. Both methods yielded similar
results.
Isolation of human peripheral PMN. Human PMN were
generously provided by the laboratory of Myron Cohen.
Leukocytes were separated from heparinized venous blood
of normal volunteers using Plasmagel (9). PMN were then
isolated as described before (2), by using Ficol-Hypaque
gradient centrifugation and hypotonic lysis of erythrocytes.
The final PMN suspension was adjusted to 1 x 107 to 2 x
107/ml in phosphate-buffered saline, pH 7.4. Cells were
tested for viability by trypan blue exclusion and were 95 to
99% viable for up to 10 h.
Chemotaxis of human PMN. Chemotaxis under agarose
was carried out essentially as reported by Nelson et al. (18).
The 1% agarose plates (SeaKem agarose; FMC Corp.,
Marine Colloids Div., Rockland, Maine) were prepared with
Dulbecco minimal essential medium, containing 10% heat-
inactivated fetal calf serum, 1% glutamine, 0.06 mg of
streptomycin per milliliter, and 0.03 mg of kanamycin per
milliliter. The plates were freshly poured each morning. Six
sets of three wells were punched along the circumference of
each plate with a beveled gel punch and a Plexiglas template
(Rohm & Haas Co., Philadelphia, Pa.). Following equilibra-
tion of plates for 30 min at 37°C in 5% C02, outer wells were
filled with a negative control (Dulbecco minimal essential
medium or phosphate-buffered saline). PMN (105) in 10%
heat-inactivated normal human serum (negative for anti-
chlamydial antibodies by an enzyme-linked immunosorbent
assay) were added to the center wells, and a positive control
or test sample was deposited in the inner wells. Zymosan-
activated serum or 10-4 M f Met-Leu-Phe were used as
positive controls. Plates were incubated at 37°C in 5% CO2
for 2 to 5 h, fixed in gluteraldehyde or methanol, and stained
with Giemsa. The degree of chemotaxis was graded accord-
ing to the following scale: 0, no migration out of the well; 1+,
migration one-third of the distance to the test well (0.8 mm);
2+, migration two-thirds of the distance to the test well (1.6
mm); I+, migration all the way to the test well (2.5 mm).
Any migration occurring in negative control wells was
subtracted from test values to correct for random locomo-
tion.
Polyclonal antibodies to C. psittaci (neutralization titer,
1:320) and C. trachomatis (enzyme-linked immunosorbent
assay titer, 1:10,000) were generated in female New Zealand
White rabbits by intravenous injection of purified EB three
times weekly over the course of several months. Opsonized
EB were prepared by incubating C. psittaci with a 1:700
dilution of antibody (immunoglobulin G fraction) and C.
trachomatis with a 1:3 dilution of unfractionated serum at
4°C for 30 min. After washing, EB alone or opsonized EB
were incubated with complement for 30 min at 37°C. Human
or rabbit serum was used as a source of complement. After
complement was incubated with a test sample or control, the
mixture was heated for 30 min at 56°C and then deposited in
a well. Such treatment leaves previously generated chemo-
tactic factors intact but will prevent the generation of addi-
tional molecules by inactivating their precursors.
Ingestion and intracellular fate of EB. PMN (usually 105)
were incubated with C. psittaci EB at multiplicities of
infection (MOI) of 100:1 or 10:1 and with C. trachomatis EB
at 1:1 under nonopsonizing conditions, i.e., in the absence of
complement and specific antibody. In some experiments EB
were centrifuged onto a monolayer of PMN (200 x g for 30
min); in most, the inoculum was not centrifuged, and both
PMN and bacteria remained in suspension. In the latter case
the total volume of the mixture was kept to a minimum
(usually 20 ,ul) to enhance interaction between the two. No
differences in uptake between the two methods were ob-
served. Samples were incubated at 37°C in 5% CO2 for
various lengths of time to allow ingestion to occur. PMN
were then separated from extracellular unattached EB by
centrifugation for 10 min at 200 x g. Some samples were
reincubated for additional time periods to determine whether
the ingested organisms could survive intracellularly. For
radiolabeled EB the number of counts precipitated by an
equal volume of 10% trichloroacetic acid (TCA) in both the
supernatants and the PMN was determined (28). Percent
uptake was defined as 1 - (TCA-precipitable counts in the
supernatants/TCA-precipitable counts in the control) x 100.
The percentage of organisms remaining intact at a given time
was defined as 1 - (TCA-precipitable counts in PMN
pellet/TCA-precipitable counts in the control - TCA-
precipitable counts in the supernatants) x 100.
Ingestion and intracellular fate of chlamydiae were also
assessed by using a biological assay. After separation of
PMN from supernatants, the phagocytes were sonicated in a
water bath to release intracellular organisms. The number of
inclusion-forming units remaining in the supernatants and in
the PMN sonicate at various time points was quantitated in
McCoy cells (for C. trachomatis) or L-929 cells (for C.
psittaci). Percent uptake and cell-associated infectivity were
calculated by using the equations given above except that
numbers of inclusions per 500 cells were substituted for
TCA-precipitable counts. The viability of infected PMN at
each time point was monitored by exclusion of trypan blue.
Cells were at least 91% viable for up to 10 h.
Transmission electron microscopy (TEM). PMN were incu-
bated with chlamydiae for a 15-min attachment and entry
period. The infected PMN were then pelleted by centrifuga-
tion. After removal of the supernatants containing un-
ingested EB, PMN were washed once in phosphate-buffered
saline. Some samples were processed immediately; others
were reincubated for various lengths of time. Primary fixa-
tion of PMN was carried out for 1 h at 25°C in 1%
gluteraldehyde prepared in Sorenson buffer. Cells were
pelleted by centrifugation and enrobed in agar. Following
extensive washing in Sorenson buffer, PMN underwent
secondary fixation in 1% osmium tetroxide for 3 h at 25°C.
The samples were thoroughly rinsed, dehydrated in increas-
ing concentrations of ethanol, and infiltrated and embedded
in Spurr. Thin sections were prepared on a Bausch and
Lomb ultramicrotome (Bausch & Lomb, Rochester, N.Y.),
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poststained with 5% uranyl acetate for 30 min, and then
stained with lead citrate for 4 min. Specimens were exam-
ined with an AEI electron microscope accelerated at 60 kV
with a 30-rLm objective aperture.
RESULTS
Chemotaxis under agarose. The initial experiments were
designed to determine if chiamydial particles themselves or
some product resulting from chlamydial metabolism could
affect the directed movement of PMN. Chlamydial EB alone
were incapable of causing directed migration of human PMN
(Table 1). However, the EB form of both species caused
chemotaxis when complement was present with or without
chlamydia-specific antibody. Thus, these organisms appear
to be able to activate the complement cascade by both the
classical and alterhate pathways. C. psittaci RB had no
apparent effect on PMN in this assay, whether the RB were
purified or contained within phagosomes derived from in-
fected L cells. We were unable to demonstrate the presence
of either a cell-free or a cell-associated by-product of infec-
tion that could mobilize human PMN. Both C. psittaci-
infected L cells as well as lyophilized, concentrated super-
natants from such infections were without effect.
Ingestion and intracellular fate of Chlamydia spp. in PMN.
When 3H-labeled C. psittaci were incubated with human
PMN, approximately half the number of intact chlamydiae in
the inoculum, as represented by TCA-precipitable counts,
were ingested within 15 min (Table 2). Data shown are the
result of an MOI of 100:1. An MOI of 10:1 provided similar
results (data not shown). The association between EB and
PMN appeared to be rapid, with no additional uptake
occurring after 15 min. The addition of C. trachomatis to
PMN at an MOI of 1:1 resulted in the internalization of
approximately 60% of the bacteria within 15 min. The ability
of ingested organisms to maintain themselves in a TCA-
precipitable form was also determined (Table 2). These
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a Average of four or more determinations with the exception of opsonized
C. trachomatis, which was done only once.
bFMLP, fMet-Leu-Phe (10-4 M).
' ZAS, Zymosan-activated serum.
d Fresh human serum heat inactivated at 56°C for 30 min.
e Suspension cells from a 20-h infection. Approximately 50% of the cells
displayed inclusions.
TABLE 2. Uptake and fate of radiolabeled Chlamydia spp. in
human PMNa
% Uptakeb % Cell-associated TCA-precipitable
Organism countsc
15 min 1 h 15 min 1 h 2 h 3 h 4 h
C. psittaci 47.1 45.8 78.0 52.2 31.5 25.7 36.6
C. trachomatis 58.9 NDd 60.6 43.8 ND ND 22.0
a Average of two to six determinations.
b Reported as 1 - (TCA-precipitable counts in supernatant/TCA-precipita-
ble counts in control) x 100.
c Reported as 1 - (TCA-precipitable counts in PMN pellet/TCA-precipita-
ble counts in control - TCA-precipitable counts in supernatants) x 100.
d ND, Not determined.
results indicate that there is considerable destruction of
chlamydiae. It should also be noted that some EB remain
intact for at least 4 h.
Radiolabeled chlamydiae have been used in this assay as
one means for obtaining quantitative data on EB uptake and
early intracellular fate. The damaging or killing of EB, as
opposed to conversion of infectious EB to non-infectious
RB, was monitored by a loss of TCA-precipitable radioiso-
tope counts, since the EB must be disrupted to the extent
that labeled nucleic acid is released. In addition, the nucleic
acid itself must be degraded to less than 10 to 20 base pairs
in size, since larger pieces will also be precipitated by TCA.
Assuming chlamydial DNA is attached to the cytoplasmic
membrane at one or more points, as has been demonstrated
for other procaryotes, remnants of the chromosome may be
left clinging to damaged EB. Such organisms could be falsely
construed as remaining intact. Thus, a limitation of these
experiments is that they are at best only an indication of the
physical integrity of the organisms and do not necessarily
yield information as to whether infectivity has been altered.
For these reasons, we also performed a biological assay to
examine the effect of human PMN on chlamydiae.
Table 3 summarizes the results of experiments in which
the supernatants and PMN were assayed for infectious
patticles rather than for TCA-precipitable counts. A 15-min
uptake period was used in each of these experiments. Both
C. psittaci and C. trachomatis appeared to be efficiently
ingested by PMN over the range of MOI employed. The
number of EB remaining in an infectious form gradually
declined with time. By 10 h the majority of ingested EB no
longer retained the ability to establish infection. However,
TABLE 3. Uptake and fate of infectious Chlamydia spp. in
human PMN'
Organism and % Uptakeb % Cell-associated infectivityc
MOI 15 min 1 h 4 h 10 h
C. psittaci
0.5:1 44.9 36.8 26.7 16.0 6.7
2:1 42.5 33.3 21.7 7.7 3.6
5:1 38.0 36.1 34.4 22.4 16.9
C. trachomatis
0.1:1 34.4 28.6 22.8 11.1 5.6
1:1 27.9 91.8 59.1 23.0 5.5
a Average of three to six determinations.
b Reported as 1 - (number of inclusions in supernatant/number of inclu-
sions in control)x 100.
c Reported as 1 - (number of inclusions in PMN pellet/number of inclusions
in control - number of inclusions in supernatants) x 100.
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there were still some EB present capable of inclusion for-
mation and, presumably, productive infection.
Conversion of EB to RB. To assess more accurately the
apparent loss of infectivity of newly internalized chlamyd-
iae, we tried to distinguish between the chlamydiacidal
activity of the host cell and the conversion of infectious EB
to noninfectious RB in normal development. The rate of
conversion of EB to RB was assayed in permissive,
nonprofessionally phagocytic cells, where phagolysosome
fusion presumably does not occur or (as may be the case
with C. trachomatis) is not effective. The drawback in this
protocol is that the kinetics of the conversion may be
different in the two types of cells.
McCoy cells and L cells were infected with C. trachomatis
and C. psittaci, respectively, according to the standard
protocol to determine infectivity. MOIs of 2:1 and 0.5:1 were
used in each experiment, and both experiments yielded
similar results. At 4 and 10 h postinoculation the host cells
were ruptured by sonication in a water bath. The chlamydiae
released in the sonicate were added to fresh host cell
monolayers, incubated to allow for inclusion development,
and stained with Giemsa. Of the C. trachomatis, 29.6% were
capable of inclusion-formation at 4 h and 7.1% at 10 h; for C.
psittaci, the percentages were 4.8 and 3.4%. C. psittaci EB
converted to RB earlier than C. trachomatis serovar E. This
was not unexpected, since the duration of the developmental
cycle of our C. trachomatis biovar was approximately twice
that of C. psittaci. When the percentages of C. psittaci and
C. trachomatis survivors in L cells and McCoy cells were
compared with those remaining associated with PMN at the
same time points (Table 3), roughly the same percentages
were obtained. Thus, the majority of the EB that escape
immediate destruction do not appear capable of delaying
their conversion to a noninfectious form.
TEM. A third experimental series was added to substan-
tiate the radioactive and biological data. TEM was used to
directly visualize internalization and to ascertain whether
morphologically intact, intracellular EB were still present
several hours after entry. Figure 1A is an electron
photomicrograph of a thin section of a human PMN that had
been incubated with C. psittaci for 15 min. Numerous
intracellular organisms were present as well as some de-
graded material. Similar findings were observed in PMN 1 h
postinoculation (data not shown). Figure 1B illustrates a
PMN infected with C. psittaci for 10 h. In this sample most
of the PMN had already lysed and were releasing intracel-
lular contents into the medium. The micrographs of C.
trachomatis-infected PMN after 15 min and 10 h are shown
in Fig. 1C and D. Although a considerable amount of
degraded material was present in the PMN, there were also
numerous, apparently intact chlamydiae present in both tight
and loose vacuoles. Of course, it is not possible to discern
from the micrographs how much of the destruction of the
infectious chlamydiae is due to the effects of PMN and how
much is due to noninfectious particles always present in a
chlamydial inoculum. Despite technical, morphological, and
quantitative limitations, the TEM observations are consis-
tent with data from the other methods, which indicate that
although there is considerable destruction of chlamydiae by
human PMN, there is also some persistence in these cells for
several hours.
DISCUSSION
At most Chlamydia-infected sites, there is a prominent
infiltration of PMN. The results reported here indicate that
chlamydiae exert a chemotactic effect on human PMN in
vitro in the presence of complement, suggesting that com-
plement activation has occurred. This is consistent with the
results of other investigators (16) who also directly measured
levels of C5a des-arginine generated by C. trachomatis. In
our experiments, chemotaxis was observed both in the
presence and in absence of chlamydiae-specific antibody.
Therefore, these organisms may be capable of alternate
pathway activation when antibody is not present in vivo.
However, even previously uninfected individuals may pos-
sess low levels of cross-reactive antibodies (5, 21). The
absence of a chemotactic substance either in culture super-
natants or in association with infected cells does not rule out
the possibility that such molecules are generated in vivo.
Alternatively, the methods used here may not be sufficiently
sensitive to demonstrate the presence of a chemoattractant.
Nonetheless, the results suggest that chlamydiae may play a
direct role in the recruitment ofPMN to the site of infection
in vivo. The question then becomes: how does the interac-
tion between recruited PMN and chlamydiae affect the
outcome of infection?
Studies on the uptake and intracellular fate of chlamydiae
were initially undertaken, in part, to confirm the work of
Yong et al. (30). They reported that after 1 h human PMN
inactivated greater than 99% of a trachoma biovar of C.
trachomatis at a low MOI. However, we found that after 1 h
approximately one-fourth to one-half of chlamydial EB
retain their infectivity in human PMN. There are some
differences in experimental protocol that may account for
these contrasting results. We conducted our experiments
under nonopsonizing conditions, i.e., in the absence of
specific antibody and complement. This is in contrast to the
work of Yong et al., where it appears complement was
present. Opsonized organisms very likely suffer a fate dif-
ferent from that of nonopsonized ones (27, 28). Whether
infecting EB would be opsonized by complement in vivo
depends on many factors, including the site of infection.
Human cervical mucus may contain small amounts of com-
plement, but the levels fluctuate according to such variables
as phase of menstrual cycle and use of oral contraceptives
(6). Another important difference is that in the previous
study C. trachomatis was centrifuged for 60 min at 1,000 x
g onto a monolayer of PMN at room temperature. The
experiments reported here were performed by incubating
chlamydiae with PMN in suspension at 37°C. We believe
these conditions more closely approximate the circum-
stances under which PMN may become infected in vivo. The
mechanism by which chlamydiae become associated with
PMN could be different under these two sets of conditions
and may result in different outcomes of infection. It was also
difficult to determine the actual number of ingested orga-
nisms in Yong's study. Finally, Yong and co-workers uti-
lized a probe tip to sonicate PMN when releasing intracel-
lular organisms. We used a water bath sonicator in an
attempt to gently lyse the PMN without also rupturing the
lysosomes. Components of the granules may have a delete-
rious effect on EB and could reduce the infectivity of any
that might persist.
The possibility exists that cell-associated organisms re-
maining infectious or acid insoluble after the uptake period
remain so not because they have thwarted the microbicidal
mechanisms of the PMN, but because they are attached and
not ingested. If this is so, these organisms might be expected
to remain in an infectious form for some time after they
associate with the PMN. This is not the case for the majority
of those EB that are cell associated at 15 min. Rather, there
is a steady loss of intact infectious bacteria over time.
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FIG. 1. Electron photomicrographs of human PMN infected with C. psittaci (A and B) or C. trachomatis (C and D). PMN were incubated
with EB (MOI, 100:1) for 15 min, pelleted by centrifugation, and washed with phosphate-buffered saline. Samples were processed
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Furthermore, we were able to observe large numbers of
intracellular chlamydiae in thin sections of PMN but only
rarely noted the presence of an attached uningested orga-
nism. Although this is by no means a quantitative determi-
nation, it does support our contention that few cell-
associated EB remain extracellular for any length of time
after the initial uptake period.
As early as 15 min postinoculation approximately 65% of
the PMN-associated EB have been rendered noninfectious.
It is presumed that phagolysosome fusion has occurred.
Others have reported the fusion of lysosomes with chla-
mydia-laden phagosomes of human PMN, both in vivo and
in vitro (11; E. C. Yong, W. J. Chen, S. J. Klebanoff, and
C. C. Kuo, Abstr. Annu. Meet. Am. Soc. Microbiol. 1983,
B67, p. 34). At 1 h there are slightly fewer infectious bacteria
remaining associated with PMN. This decrease may reflect
the killing of EB that became attached and ingested near the
end of the uptake period. Data on the conversion of EB to
RB in L cells indicates that by 4 h only about 5% of C.
psittaci and roughly 30% of C. trachomatis retain the ability
to form inclusions. These numbers approximate the number
of infectious organisms persisting at the same time point in
PMN. Therefore, loss of infectivity in PMN occurring later
than 1 h (or 45 min after the uptake period) may be due to the
conversion of EB to RB. This possibility is supported by the
fact that when phagolysosome fusion occurs it generally
takes place within 5 to 30 min of ingestion (7,13). By 1 h this
process should be complete. However, there are some
factors complicating our interpretation of these results.
Soderlund and colleagues found that C. trachomatis elicited
a peak chemiluminescence response in human PMN 60 min
after addition of bacteria (23). Although chemiluminescence
is not a direct measure of phagolysosome fusion, such a
result could indicate that this event occurs at a slower rate
with chlamydiae than with bacteria that grow extracellularly.
In addition, we have made the assumption that once
phagolysosome fusion does occur, chlamydiae are actually
killed fairly rapidly-within 30 to 60 min. Finally, the rate at
which EB convert to RB may differ significantly from one
EB to another in the population. Considerations such as
these make the precise determination of intracellular events
difficult. However, it is clear that whatever the mechanism,
a small percentage of C. psittaci and C. trachomatis EB are
capable of remaining intact and infectious for a considerable
period of time in human PMN, in spite of the fact that at least
half the infecting organisms are rapidly inactivated in these
cells. Under conditions used in the present study the per-
centage of inclusion-forming units remaining at 10 h repre-
sented 500 (MOI, 0.1:1) to 84,000 (MOI, 5:1) EB.
Time is an important element when considering the ulti-
mate fate of these organisms in a cell as short-lived as a
PMN. Those EB that escape the immediate chlatmydiacidal
action of PMN must be able to mnaintain themselves in an
infectious state if they are eventually to resume a productive
infection in the host. EB that begin the conversion to RB
would not have sufficient time to complete the developmen-
tal cycle and would be released as RB at the time of cell
death. These noninfectious chlamydiae would ultimately
suffer the same fate as those actively destroyed by the PMN.
However, the small number of EB that retain their infectiv-
ity would be capable of infecting macrophages or epithelial
cells once they are released extracellularly from the dying
PMN. Alternatively, PMN infected with chlamydiae may be
engulfed by macrophages arriving at the site of infection.
Metchnikoffwas the first to observe phagocytosis of infected
PMN by macrophages (17), and his observation has recently
been more thoroughly investigated (3, 20). Those EB that
persist in the PMN may now initiate productive infection in
the macrophage. Infected inflammatory macrophages may
even serve as a vehicle in the dissemination of infection.
The question of what is responsible for the observed
inactivation of Chlamydia spp. remains unanswered. It has
been shown that C. trachomatis is highly susceptible to a
cell-free myeloperoxidase-H202-halide system (30). How-
ever, myeloperoxidase-deficient human PMN have inacti-
vated C. trachomatis to the same extent as normal PiN. In
addition, PMN incapable of generating a respiratory burst,
obtained from patients with chronic granulomatous disease,
were less effective at inactivating a trachoma biovar but
were still strongly microbicidal. These results suggest that
although the oxygen-dependent microbicidal systems of the
human PMN are capable of inactivating C. trachomatis,
these organisms must also be susceptible to killing by one or
more of the nonoxidative lysosomal components. Currently,
efforts are being directed towards the investigation of this
important question.
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